Normotus Antitussive (Dextromethorphan Hydrobromide)

Dextromethorphan suppresses coughing by acting as a sigma‑1 receptor agonist and an NMDA receptor antagonist. These actions reduce neuronal excitability in the medullary cough centre, decreasing the cough reflex without affecting normal breathing patterns.

The appropriate dose is determined by the prescriber or according to the product label. For most OTC formulations, adults may take 10‑20 mg every 4‑6 hours, not exceeding the maximum daily amount indicated on the packaging. Children’s dosing follows age‑specific recommendations provided by a healthcare professional.

Safety data for dextromethorphan in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and only after consulting a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with opioid‑based suppressants such as codeine, dextromethorphan offers a non‑opioid option with a lower risk of dependence and respiratory depression. However, it may interact with serotonergic agents, whereas codeine carries a higher potential for sedation and gastrointestinal side effects.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Normotus Antitussive is taken orally. Swallow the tablet whole with a glass of water. It can be taken with or without food, although taking it with food may reduce mild gastrointestinal discomfort in some individuals.

Serious adverse reactions include allergic responses such as rash or swelling, serotonin syndrome when combined with serotonergic drugs, severe dizziness or hallucinations, and, rarely, respiratory depression. Prompt medical attention is required if any of these symptoms occur.

Individuals with known hypersensitivity to dextromethorphan, children under four years of age, and patients currently receiving monoamine oxidase inhibitors should avoid this medication. Consultation with a healthcare professional is also advised for anyone with significant liver impairment or a history of serotonin‑related disorders.